CHA Comments on Stimulant Medication Shortages

CHA Comments on Stimulant Medication Shortages

Children’s health groups are asking HHS and the DEA to convene stakeholders to identify actionable solutions about ongoing stimulant medication shortages.
Download

Children's Hospital Association and other children’s health groups submitted joint comments to the Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) requesting the convening of stakeholders to identify actionable solutions about ongoing stimulant medication shortages.

Our comments highlight the long-term negative impacts that children and their families may experience due to untreated attention deficit hyperactivity disorder and that these shortages exacerbate existing health disparities among families enrolled in Medicaid and CHIP.

Related Content

CHA Applauds House Committee’s Passage of Crucial Children’s Health Legislation

The Accelerating Kids’ Access to Care Act addresses gaps and delays in access to critical out-of-state care for children.

June 12, 2024

Addressing Pediatric Drug and Supply Shortages

Children’s hospitals depend on a reliable and safe drug and supply chain to provide life-saving treatments to their pediatric patients.

June 11, 2024

Children’s Hospitals Celebrate 2024 Community Health Improvement Week

Community Health Improvement Week highlights the efforts of hospitals and community organizations working to improve health outcomes in their communities.

June 10, 2024